
Profound Medical Corp. (PROF) Stock Ticker
PROF right now
Market factors today
Unlock the full PROF picture
About Profound Medical Corp.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
PROF stock facts
| Ticker symbol | PROF |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $209.3M |
| CEO | Arun Swarup Menawat |
| Employees | 162 |
| Headquarters | Mississauga, ON, CA |
| IPO date | 2019-10-29 |
| Website | www.profoundmedical.com |
What you can see for PROF on Tickr
Live PROF price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PROF report.
Rankings
FAQ
What is the ticker symbol for Profound Medical Corp.?
The ticker symbol for Profound Medical Corp. is PROF, listed on the NASDAQ Capital Market.
What is PROF?
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the…